Minimally invasive technology temporarily reverses brain blood flow, treats
carotid artery disease
Baton Rouge, La. – Recently, a patient at Baton Rouge General was among the first
in the country to benefit from a new stroke prevention procedure. Dr.
Vince Weaver, a vascular surgeon with Baton Rouge Vascular Specialty Center,
is the first physician in South Louisiana and the only physician in Baton
Rouge to perform a new, minimally invasive procedure that reverses the
blood flow through the brain to divert blood clots and plaque away from
the brain to prevent blockage and stroke.
“Strokes can be tragic and life-altering, and I’m thrilled
to be able to offer such an important new option in the fight against
them,” said Dr. Weaver. “TCAR is particularly suited for the
large portion of patients we see who are at higher risk of complications
from other traditional procedures. Because of the TCAR procedure’s
low stroke risk, we think it has the potential to become the standard
of care for all patients.”
In this new minimally invasive procedure, called TransCarotid Artery Revascularization
or TCAR, through a small incision at the base of the neck, physicians
temporarily reverse the blood flow in the carotid artery prior to placing
a stent in one of the patient’s neck arteries to prevent blockage
from clogging arteries and potentially leading to stroke.
“TCAR is able to provide patients with the safest possible treatment
option for patients with carotid artery disease,” said Dr. Weaver.
Before this procedure, the main treatment option for high risk patients
with blocked carotid arteries was open surgery, which increases risk of
stroke, heart attack, and cranial nerve injuries that can cause issues
with swallowing, speaking, and sensation in the face. The alternate procedure
for patients with previous neck surgery, difficult anatomy or radiation
treatment has an even higher risk of stroke.
In addition to lower risk, patients can also expect a faster and less painful
recovery with TCAR. Dr. Weaver said, “The hour-long surgery went
smoothly, and we expect TCAR patients to be discharged from the hospital
the morning after surgery.”
Every year, 15 million people worldwide suffer from strokes. Nearly six
million die and another five million are left permanently disabled. Stroke
is the second leading cause of disability worldwide, and is the number
four cause of death in Louisianians each year. Carotid artery disease
is estimated to be the source of stroke in up to a third of cases.
To learn more about stroke prevention and the TCAR procedure, register at
BRGeneral.org for a free lunch seminar at BRG on
About Baton Rouge General Medical Center
Baton Rouge General Medical Center is the area’s first community
hospital with 588 licensed beds between two campuses. Baton Rouge General
opened its doors in 1900, and has provided the Greater Baton Rouge community
with high-quality healthcare for generations. An accredited teaching hospital
since 1991, Baton Rouge General serves as a satellite campus of Tulane
University School of Medicine, and offers other medical education programs,
including a School of Nursing, School of Radiologic Technology, Family
Medicine Residency Program, Internal Medicine Residency Program, and Sports
Medicine Fellowship Program. For more information, visit
BRGeneral.org, find us on Facebook at
Facebook.com/BatonRougeGeneral and follow us on Twitter at
About Vascular Specialty Center
Baton Rouge Vascular Specialty Center (VSC) provides care from fellowship-trained,
board-certified, experienced leaders in vascular care who have served
Baton Rouge and southern Louisiana with distinction for more than 30 years.
Our professional, friendly vascular team has helped thousands of patients
just like you. For more information, visit
brvsc.com or call 225-399-4472.
About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System The ENROUTE® Transcarotid Neuroprotection (NPS) and Stent System from
Silk Road Medical, Inc. are the first devices designed and FDA-approved
specifically for TCAR. The ENROUTE Transcarotid Stent is indicated for
use in High Surgical Risk patients and is intended to be used in conjunction
with the ENROUTE Transcarotid Neuroprotection System (NPS). The ENROUTE
Transcarotid NPS is used to directly access the common carotid artery
and initiate high rate temporary blood flow reversal to protect the brain
from stroke while delivering and implanting the ENROUTE Transcarotid Stent.